[go: up one dir, main page]

NO20074929L - Influensa terapeutisk middel - Google Patents

Influensa terapeutisk middel

Info

Publication number
NO20074929L
NO20074929L NO20074929A NO20074929A NO20074929L NO 20074929 L NO20074929 L NO 20074929L NO 20074929 A NO20074929 A NO 20074929A NO 20074929 A NO20074929 A NO 20074929A NO 20074929 L NO20074929 L NO 20074929L
Authority
NO
Norway
Prior art keywords
rnai
influenza
inducing
influenza virus
provides
Prior art date
Application number
NO20074929A
Other languages
English (en)
Norwegian (no)
Inventor
Jianzhu Chen
Herman N Eisen
Qing Ge
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/102,097 external-priority patent/US20060160759A1/en
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of NO20074929L publication Critical patent/NO20074929L/no

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20074929A 2005-03-22 2007-09-28 Influensa terapeutisk middel NO20074929L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66458005P 2005-03-22 2005-03-22
US11/102,097 US20060160759A1 (en) 2002-09-28 2005-04-08 Influenza therapeutic
PCT/US2006/010491 WO2006102461A2 (fr) 2005-03-22 2006-03-22 Therapeutique antigrippale

Publications (1)

Publication Number Publication Date
NO20074929L true NO20074929L (no) 2007-12-18

Family

ID=39406020

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074929A NO20074929L (no) 2005-03-22 2007-09-28 Influensa terapeutisk middel

Country Status (5)

Country Link
JP (1) JP2008533990A (fr)
CN (1) CN101180395A (fr)
IL (1) IL186057A0 (fr)
MX (1) MX2007011665A (fr)
NO (1) NO20074929L (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103966212A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒NP基因有干扰作用的siRNA序列的设计及应用
CN103966214A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒PB基因有干扰作用的siRNA序列的设计及应用
CN103966213A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒M基因有干扰作用的siRNA序列的设计和干扰作用的鉴定
AU2014281028B2 (en) * 2013-06-17 2020-09-10 Massachusetts Institute Of Technology Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy
ES2796930T3 (es) * 2014-01-23 2020-11-30 Univ Colorado State Res Found Silenciamiento de ARNip mediado por E. coli de la gripe aviar en pollos
CN106381296A (zh) * 2015-11-19 2017-02-08 中国农业科学院哈尔滨兽医研究所 表达多基因抗流感转基因动物的构建方法
CN106947763B (zh) * 2017-03-20 2019-11-12 中国医学科学院医药生物技术研究所 可雾化吸入的抗流感病毒感染的siRNA及其应用
JP7693548B2 (ja) 2019-02-01 2025-06-17 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 肺への核酸送達のための犠牲細胞透過性複合体
CN114206906B (zh) * 2019-07-10 2024-02-20 香港大学 Peg化的合成kl4肽、其组合物和方法

Also Published As

Publication number Publication date
CN101180395A (zh) 2008-05-14
IL186057A0 (en) 2008-01-20
JP2008533990A (ja) 2008-08-28
MX2007011665A (es) 2007-11-14

Similar Documents

Publication Publication Date Title
NO20074929L (no) Influensa terapeutisk middel
WO2006102461A3 (fr) Therapeutique antigrippale
US10167474B2 (en) Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore
Yu et al. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice
Ivashchenko et al. How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoV
Xie et al. Cryptosporidium parvum induces SIRT1 expression in host epithelial cells through downregulating let-7i
AU2019203090B2 (en) E.COLI MEDIATED siRNASILENCING OF AVIAN INFLUENZA IN CHICKENS
JP2019508045A (ja) がんを処置するための組み合わせベクターおよび方法
Samir et al. Small non-coding RNAs associated with viral infectious diseases of veterinary importance: potential clinical applications
Li et al. RETRACTED: MicroRNA‐425‐3p inhibits myocardial inflammation and cardiomyocyte apoptosis in mice with viral myocarditis through targeting TGF‐β1
Zhou et al. Targeting RPTPσ with lentiviral shRNA promotes neurites outgrowth of cortical neurons and improves functional recovery in a rat spinal cord contusion model
Lee et al. ROS-mediated bidirectional regulation of miRNA results in distinct pathologic heart conditions
Stoppani et al. Expression of a single siRNA against a conserved region of NP gene strongly inhibits in vitro replication of different Influenza A virus strains of avian and swine origin
US20120039905A1 (en) The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
Huang et al. Host microRNA-217 promotes white spot syndrome virus infection by targeting tube in the Chinese mitten crab (Eriocheir sinensis)
Guo et al. Activated NETosis of bone marrow neutrophils up-regulates macrophage osteoclastogenesis via cGAS-STING/AKT2 pathway to promote osteoporosis
Wang et al. Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome
JP2023513188A (ja) 遺伝子の発現増加のためのｍｉｒｎａ－４８５阻害剤
JP4054844B2 (ja) 副作用のないＲＮＡｉ医薬
Jia et al. Specific small interfering RNAs-mediated inhibition of replication of porcine encephalomyocarditis virus in BHK-21 cells
Zhao et al. Host-specific SRSF7 regulates polymerase activity and replication of influenza A virus
Chu et al. ASFV infection induces lipid metabolic disturbances and promotes viral replication
Lian et al. The BLV-miRNAs pathway of BLV inhibits the expression of Lactoferrin, Lactoperoxidase, Alpha-lactalbumin and Beta-lactoglobulin proteins
Mahesh Study of Double-Stranded RNA Recognition Receptors Mediated Innate Immune Responses Using Knockout Quail Cells
Sautchuk Jr Role of the mitochondrial energy metabolism in osteogenic response during mechanical loading

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application